AI Assistant
Blog
Pricing
Log In
Sign Up
Progression to end-stage renal disease is reduced with eculizumab in patients with atypical haemolytic uraemic syndrome
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
